-------------------------------------------------------------------------
-------------------------------------------------------------------------
Statements of Operations and Comprehensive Loss and Deficit (unaudited)
Years ended September 30 2007 2006
$ $
REVENUES
Sales (including rental income of
$839,460; 2006 - $320,862) 39,692,191 38,375,896
Cost of sales (including amortization and
console write-downs of $2,789,709; 2006
- $4,245,556) 16,202,821 17,824,668
-------------------------------------------------------------------------
Gross Profit 23,489,370 20,551,228
Surgical distribution rights - 233,358
Interest income 23,489,370 20,784,586
727,198 531,978
-------------------------------------------------------------------------
24,216,568 21,316,564
-------------------------------------------------------------------------
-------------------------------------------------------------------------
EXPENSES
Research and development 12,591,208 11,829,618
Investment tax credits (717,195) (944,172)
-------------------------------------------------------------------------
Net research and development 11,874,013 10,885,446
Administrative 7,574,336 5,963,916
Sales and marketing 24,694,626 27,430,009
Amortization a
'/>"/>
| SOURCE CryoCath Technologies Inc. Copyright©2007 PR Newswire. All rights reserved |